Latest Cancer News

Novel Agent Granted Fast Track Designation for Refractory Metastatic Colorectal Cancer (10-23-2014)
The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to TAS-102, a novel agent currently under investigation for the treatment of refractory metastatic colorectal cancer. According... Continue Reading

FDA Grants Breakthrough Therapy Designation to AP26113 for ALK-Positive NSCLC (10-22-2014)
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to an investigational agent AP26113 for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non–small... Continue Reading

Adding Cediranib to Olaparib Markedly Improves Progression-Free Survival but Increases Toxicity in Recurrent Platinum-Sensitive Ovarian Cancer (10-21-2014)
The addition of the antiangiogenic agent cediranib to the PARP inhibitor olaparib in women with recurrent platinum-sensitive ovarian cancer improves time to cancer progression and survival. The results... Continue Reading

More Cancer News

Locations

MONTEREY
5 Harris Court, Building T, Suite 201
Monterey, CA 93940
(phone) 831-375-4105 (fax) 831-372-5722
Click here for map

 

MORGAN HILL
18525 Sutter Boulevard, Suite 170
Morgan Hill, CA 95037
(phone) 408-779-9843 (fax)408-779-9874
Click here for map

 

SALINAS
505 East Romie Lane, Suite A
Salinas, CA 93901
(phone) 831-755-1701 (fax)831-755-1702
Click here for map